Privia Health shares slip over 2% as 2025 guidance falls short

Published 27/02/2025, 12:36
Privia Health shares slip over 2% as 2025 guidance falls short

ARLINGTON, Va. -On Thursday, Privia Health Group , Inc. (NASDAQ:PRVA) reported fourth-quarter results that beat analyst expectations, even as the company’s 2025 revenue guidance came in below consensus estimates.

The company’s shares fell -2.33% in pre-market trading.

The physician enablement company posted adjusted earnings per share of $0.21, surpassing the analyst estimate of $0.05. Revenue for the quarter reached $460.9 million, exceeding the consensus forecast of $420.94 million and representing a 4.6% increase from the same period last year.

For the full year 2024, Privia Health reported revenue of $1.74 billion, up 4.7% YoY. Adjusted EBITDA grew 25.2% to $90.5 million.

However, the company’s 2025 revenue guidance of $1.8-1.9 billion fell short of analysts’ expectations of $1.89 billion. Privia Health cited a challenging Medicare Advantage and value-based care environment as factors impacting its outlook.

The company ended 2024 with $491.1 million in cash and no debt. It generated $109.3 million in operating cash flow for the year, up 35.3% from 2023.

Privia Health expects to increase its implemented providers to 5,200-5,300 in 2025, representing 8.6-10.7% growth. The company also forecasts adjusted EBITDA of $105-110 million for 2025, up 16.1-21.6% YoY.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.